Lymphocyte activation in health and disease

Critical Reviews in Immunology

Volumn 17, Issue 2, 1997, Pages 155-178

  Berridge, Michael J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

apoptosis; calcium; CD28; ceramide; Fas; gene transcription; IL 2; inositol trisphosphate; proliferation; protein kinase C; ras

Indexed keywords

CALCIUM ION; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; FAS ANTIGEN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SPHINGOMYELIN PHOSPHODIESTERASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE; TRANSCRIPTION REGULATION;

EID: 0030942048     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v17.i2.30     Document Type: Review

References (155)

1. Weiss, A. and Littman, D. R., Signal transaction by lymphocyte antigen receptors, Cell, 76, 263, 1994.
2. Zenner, G., zur Hausen, J. D., Burn, P., and Mustelin, T., Towards unravelling the complexity of T-cell signal transduction, BioEssays, 17, 967, 1995.
3. Cantrell, D., T cell antigen receptor signal transduction pathways, Annu. Rev. Immunol., 14, 259, 1996.
4. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T-cell activation, Annu. Rev. Immunol., 14, 1, 1996.
5. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B., The B7 and CD28 receptor families, Immunol. Today, 15, 321, 1994.
6. DeFranco, A. L., Transmembrane signaling by antigen receptors of B and T lymphocytes, Curr. Opin. Cell Biol., 7, 163, 1995.
7. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs, Cell, 60, 755, 1990.
8. Rafnar, T., Catipovic, B., Brummet, M. E., Schneck, J. P., and Marsh, D. G., CSK associates with the epsilon-chains and zeta-chains of the TCR via its SH2 domain, J. Allergy Clin. Immunol., 95, 176, 1995.
9. Okumura, M. and Thomas, M. L., Regulation of immune function by protein tyrosine phosphatases, Curr. Opin. Immunol., 7, 312, 1995.
10. + thymocytes and in B cell maturation, J. Exp. Med., 183, 1707, 1996.
11. Plas, D. R., Johnson, R., Pingel, J. T., Matthews, R. J., Dalton, M., Roy, G., Chan, A. C., and Thomas, M. L., Direct regulation of ZAP-70 by SHP-1 in T-cell antigen receptor signaling, Science, 272, 1173, 1996.
12. Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W., and Krystal, G., The 145-kDa protein-induced to associated with SHC by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphophate 5-phosphatase, Proc. Natl. Acad. Sci. U.S.A., 93, 1689, 1996.
13. Kavanaugh, W. M., Pot, D. A., Chin, S. M., Deuter-Reinhard, M., Jefferson, A. B., Norris, F. A., Masiarz, F. R., Cousens, L. S., Majerus, P. W., and Williams, L. T., Multiple forms of an isositol polyphosphate 5-phosphatase form signaling complexes with SHC and GRB2, Curr. Biol., 6, 438, 1996.
14. Stephens, L., Jackson, T. R., and Hawkins, P. T., Activation of phosphatidylinositol 4,5-bisphosphate supply by agonists and nonhydrolyzable GTP analogs, Biochem. J., 296, 481, 1993.
15. Wu, L., Niemeyer, B., Colley, N., Socolich, M., and Zuker, C. S., Regulation of PLC-mediated signaling in vivo by CDP-diacylglycerol, Nature, 373, 216, 1995.
16. Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A., The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells, Cell, 79, 507, 1994.
17. 2+, J. Immunol., 150, 5338, 1993.
18. Negulescu, P. A., Shastri, N., and Cahalan, M. D., Intracellular calcium dependence of gene expression in single T lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 91, 2873, 1994.
19. 2+ current in human leukemic T cells, Cell Regul., 1, 99, 1989.
20. Donnadieu, E., Bismuth, G., and Trautman, A., Calcium fluxes in lymphocytes-T, J. Biol. Chem., 267, 25864, 1992.
21. 2+ stores, Proc. Natl. Acad. Sci. U.S.A., 90, 6295, 1993.
22. 2+], oscillations in T lymphocytes, J. Gen. Physiol., 103, 365, 1994.
23. Lewis, R. S. and Cahalan, M. D., Potassium and calcium channels in lymphocytes, Annu. Rev. Immunol., 13, 623, 1995.
24. 2+ signaling, Cell Calcium, 17, 287, 1995.
25. Berridge, M. J., Capacitative calcium entry, Biochem. J., 312, 1, 1995.
26. CRAC in the eye, Curr. Biol. 5, 1225, 1995.
27. Bram, R. J. and Crabtree, G. R., Calcium signalling in T cells stimulated by a cyclophilin B-binding protein, Nature, 371, 355, 1994.
28. Berridge, M. J., Inositol trisphosphate and calcium signalling, Nature, 361, 315, 1993.
29. Berridge, M. J., Calcium signalling and cell proliferation, BioEssays, 17, 491, 1995.
30. Fischer, M. B., Wolf, H. M., Hauber, I., Eggenbauer, H., Thon, V., Sasgary, M., and Eibl, M. M., Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency, Eur. J. Immunol., 26, 231, 1996.
31. Jayaraman, T., Ondriasova, E., Ondrias, K., Harnick, D. J., and Marks, A. R., The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling, Proc. Natl. Acad. Sci. U.S.A., 92, 6007, 1995.
32. Jayaraman, T., Ondrias, K., Ondriasova, E., and Marks, A. R., Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation, Science, 272, 1492, 1996.
33. Partiseti, M., Le Deist, F., Hivroz, C., Fischer, A., Korn, H., and Choquet, D., The calcium current activated by T-cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency, J. Biol. Chem., 269, 32327, 1994.
34. Serafini, A. T., Lewis, R. S., Clipstone, N. A., Bram, R. J., Fanger, C., Fiering, C., Herzenberg. L. A., and Crabtree, G. R., Isolation of mutant T lymphocytes with defects in capacitative calcium entry, Immunity, 3, 239, 1995.
35. Fanger, C. M., Hoth, M., Crabtree, G. R., and Lewis, R. S., Characterization of T-cell mutants with defects in capacitative calcium entry: genetic evidence for the physiological roles of CRAC channels, J. Cell Biol., 131, 655, 1995.
36. Shivnan, E., Clayton, L., Alldridge, L., Keating, K. E., Gullberg, M., and Alexander, D., CD45 monoclonal antibodies inhibit TCR-mediated calcium signals, calmodulin-kinase IV/Gr activation, andoncoprotein 18 phosphorylation, J. Immunol., 157, 101, 1996.
37. Hanash, S. M., Strahler, J. R., Kuick, R., Chu, E. H. Y., and Nichols, D., Identification of a polypeptide associated with the malignant phenotype in acute leukemia, J. Biol. Chem., 263, 12813, 1988.
38. + T cells, Eur. J. Immunol., 25, 2445, 1995.
39. Donnadieu, E., Bismuth, G., and Trautmann, A., Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium, Curr. Biol., 4, 584, 1994.
40. Negulescu, P. A., Krasieva, T. B., Khan, A., Kerschbaum, H. H., and Cahalan, M. D., Polarity of T-cell shape, motility, and sensitivity to antigen, Immunity, 4, 421, 1996.
41. Nishizuka, Y., Protein kinase C and lipid signaling for sustained cellular responses, FASEB J., 9, 484, 1995.
42. Genot, E. M., Parker, P. J., and Cantrell, D. A., Analysis of the role of protein kinase C-α, -ε and -ζ in T-cell activation, J. Biol. Chem., 270, 9833, 1995.
43. Pawson, T., Protein modules and signalling networks, Nature, 373, 573, 1995.
44. Malarkey, K., Belham, C. M., Paul, A., Graham, A., McLees, A., Scott, P. H., and Plevin, R., The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors, Biochem. J., 309, 361, 1995.
45. Nel, A. E., Gupta, S., Lee, L., Ledbetter, J. A., and Kanner, S. B., Ligation of the T-cell antigen receptor (TCR) induces association of hSos1, ZAP-70, phospholipase C-γ1, and other phosphoproteins with Grb2 and the ζ-chain of the TCR, J. Biol. Chem., 270, 18428, 1995.
46. Kapeller, R. and Cantley, L. C., Phosphatidylinoisitol 3-kinase, BioEssays, 16, 565, 1994.
47. Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A., Inhibition of glycogen-synthase kinase-3 by insulin-mediated by protein-kinase-B, Nature, 378, 785, 1995.
48. Burgering, B. M. T. and Coffer, P. J., Protein-kinase-B (C-AKT) in phosphatidylinositol-3-OH inase signal-transduction. Nature, 376, 599, 1995.
49. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreiber, S. L., Control of p70 S6 kinase by kinase-activity of FRAP in vivo. Nature, 377, 441, 1995.
50. Hawkins, P. T., Eguinoa, A., Qiu, R. G., Stokoe, D., Cooke, F. T., Walters, R., Wennstrom, S., Claessonwelsh, L., Evans, T., Symons, M., and Stephens, L., PDGF stimulates an increase in GTP-RAC via activation of phosphoinositide 3-kinase, Curr. Biol., 5, 393, 1995.
51. Stowers, L., Yelon, D., Berg, L. J., and Chant, J., Regulation of the polarization of T cells toward antigen-presenting cells by ras-related GTPase CDC42, Proc. Natl. Acad. Sci. U.S.A., 92, 5027, 1995.
52. Glotzer, M. and Hyman, A. A., Cell polarity - the importance of being polar, Curr. Biol., 5, 1102, 1995.
53. Schwartz, R. H., Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy, Cell, 71, 1065, 1992.
54. Boussiotis, V. A., Gribben, J. G., Freeman, G. J., and Nadler, L. M., Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance, Curr. Opin. Immunol., 6, 797, 1994.
55. Mueller, D. L. and Jenkins, M. K., Molecular mechanisms underlying functional T-cell unresponsiveness, Curr. Opin. Immunol., 7, 375, 1995.
56. Lenschow, D. J., Walunas, T. L., and Bluestone, J. A., CD28/B7 system of T-cell costimulation, Annu. Rev. Immunol., 14, 233, 1996.
57. Linsley, P. S., Nadler, S. G., Bajorath, J., Peach, R., Leung, H. T., Rogers, J., Bradshaw, J., Stebbins, M., Leytze, G., Brady, W., Malacko, A. R., Marquardt, H., and Shaw, S. -Y., Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4): a disulfide-tinked homodimer binds two CD86 molecules, J. Biol. Chem., 270, 15417, 1995.
58. Raab, M., Cai, Y. C., Bunnell, S. C., Heyeck, S. D., Berg, L. J., and Rudd, C. E., P56 (lck) and P59 (fyn) regulate CD28 binding to phospatidylinositol 3-kinase, growth-factor receptor-bound protein GRB-2, and T-cell-specific protein-tyrosine kinase-ITK - implications for T-cell costimulation, Proc. Natl. Acad. Sci. U.S.A., 92, 8891, 1995.
59. Hutchcroft, J. E., Franklin, D. P., Tsai, B., Harrison-Findik, D., Varticovski, L., and Bierer, B. E., Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface-receptor, Proc. Natl. Acad. Sci. U.S.A., 92, 8808, 1995.
60. Lu, Y. L., Phillips, C. A., and Trevillyan, J. M., Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T-cells - studies with a selective inhibitor, wortmannin, Eur. J. Immunol., 25, 533, 1995.
61. Truitt, K. E., Shi, J., Gibson, S., Segal, L. G., Mills, G. B., and Imboden, J. B., CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase, J. Immunol., 155, 4702, 1995.
62. Ward, S. G., Wilson, A., Turner, L., Westwick, J., and Sansom, D. M., Inhibition of CD28-mediated T-cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin, Eur. J. Immunol., 25, 526, 1995.
63. Ghiotto-Ragueneau, M., Battifora, M., Truneh, A., Waterfield, M. D., and Olive, D., Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T-cells - phosphatidylinositol 3-kinase association to CD28 and cytokine production, Eur. J. Immunol., 26, 34, 1996.
64. Crooks, M. E. C., Littman, D. R., Carter, R. H., Fearon, D. T., Weiss, A., and Stein, P. H., CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation, Mol. Cell. Biol., 15, 6820, 1995.
65. Nunes, J. A., Collette, Y., Truneh, A., Olive, D., and Cantrell, D. A., The role of P21 (ras) in CD28 signal-transduction - triggering of CD28 with antibodies, but not the ligand B7-1, activates P21 (ras), J. Exp. Med., 180, 1067, 1994.
66. Boucher, L. M., Wiegmann, K., Futterer, A., Pfeffer, K., Machleidt, T., Schutze, S., Mak, T. W., and Kronke, M., CD28 signals through acidic sphingomyelinase, J. Exp. Med., 181, 2059, 1995.
67. Kolesnick, R. and Fuks, Z., Ceramide: a signal for apoptosis or mitogenesis, J. Exp. Med., 181, 1949, 1995.
68. Hannun, Y. A. and Obeid, L. M., Ceramide - an intracellular signal for apoptosis, TIBS, 20, 73, 1995.
69. + T cells, Science, 271, 1271, 1996.
70. + T cells, Science, 271, 1276, 1996.
71. Kang, S. -M., Beverly, B., Tran, A. -C, Brorson, K., Schwartz, R. H., and Lenardo, M. J., Transactivation by AP-1 is a molecular target of T-cell clonal anergy, Science, 257, 1134, 1992.
72. Urich, M., Elshemerly, M. Y. M., Besser, D., Nagamine, Y., and Ballmerhofer, K., Activation and nuclear translocation of mitogen-activated protein-kinases by polyomavirus middle-T or serum depend on phospatidylinositol 3-kinase, J. Biol. Chem., 270, 29286, 1995.
73. Hu, Q., Klippel, A., Muslin, J., Fantl, W. J., and Williams, L. T., Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase, Science, 268, 100, 1995.
74. Yao, B., Zhang, Y. H., Delikat, S., Mathias, S., Basu, S., and Kolesnick, R., Phosphorylation of raf by ceramide-activated protein-kinase, Nature, 378, 307, 1995.
75. Gajewski, T. F., Qian, D. P., Fields, P., and Fitch, F. W., Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways, Proc. Natl. Acad. Sci. U.S.A., 91, 38, 1994.
76. Plopper, G. E., McNamee, H. P., Dike, L. E., Bojanowski, K., and Ingber, D. E., Convergence of integrin and growth-factor receptor signaling pathways within the focal adhesion complex, Mol. Biol. Cell, 6, 1349, 1995.
77. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B., and Allen, P. M., Partial T-cell signaling - altered phospho-zeta and lack of ZAP70 recruitment in APL-induced T-cell anergy, Cell, 79, 913, 1994.
78. Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E., and Germain, R. N., Zeta-phosphorylation without ZAP-70 activation-induced by TCR antagonists or partial agonists, Science, 267, 515, 1995.
79. Djurhuus, R., Svardal, A. M., and Ueland, P. M., Growth-state independent increase of glutathione by homocysteine and other thiols, and homocysteine formation in glutathione depleted mouse-cell lines, Blochem. Pharm., 39, 421, 1990.
80. Ishii, T., Bannai, S., and Sugita, Y., Mechanism of growth-stimulation of L1210 cells by 2-mercaptoethanol in vitro - role of the mixed disulfide of 2-mercaptoethanol and cysteine, J. Biol. Chem., 256, 2387, 1981.
81. Chen, G., Wang, S. H., and Converse, C. A., Glutathione increases interleukin-2 production in human lymphocytes, Int. J. Immunopharm., 16, 755, 1994.
82. Kavanagh, T. J., Grossmann, A., Jaecks, E. P., Jinneman, J. C., Eaton, D. L., Martin, G. M., and Rabinovitch, P. S., Proliferative capacity of human peripheral-blood lymphocytes sorted on the basis of glutathione content, J. Cell Physiol., 145, 472, 1990.
83. Ferraris, A. M., Rolfo, M., Mangerini, R., and Gaetani, G. F., Increased glutathione in chronic lymphocytic-leukemia lymphocytes, Am. J. Hematol., 47, 237, 1994.
84. Walsh, A. C., Michaud, S. G., Malossi, J. A., and Lawrence, D. A., Glutathione depletion in human T-lymphocytes - analysis of activation-associated gene-expression and the stress-response, Toxicol. Appl. Pharmacol., 133, 249, 1995.
85. Staal, F. J. T., Anderson, M. T., Staal, G. E. J., Herzenberg, L. A., Gitler, C., and Herzenberg, L. A., Redox regulation of signal-transduction - tyrosine phosphorylation and calcium influx, Proc. Natl. Acad. Sci. U.S.A., 91, 3619, 1994.
86. Buttke, T. M. and Sandstrom, P. A., Oxidative stress as a mediator of apoptosis, Immunol. Today, 15, 7, 1994.
87. lck tyrosine protein kinase, Mol. Cell Biol., 10, 1853, 1990.
88. Kanner, S. B., Kavanagh, T. J., Grossmann, A., Hu, S. L., Bolen, J. B., Rabinovitch, P. S., and Ledbetter, J. A., Sulfhydryl oxidation down-regulates T-cell signaling and inhibits tyrosine phosphorylation of phospholipase C-γ-1, Proc. Natl. Acad. Sci. U.S.A., 89, 300, 1992.
89. Zhou, G. C., Denu, J. M., Wu, L., and Dixon, J. E., The catalytic role of cys(124) in the dual-specificity phosphatase VHR, J. Biol. Chem., 269, 28084, 1994.
90. + lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase-activity which is enhanced by antioxidants, Clin. Exp. Immunol., 104, 11, 1996.
91. Abate, C., Luk, D., Gentz, R., Rauscher, F. J., and Curran, T., Expression and purification of the leucine zipper and DNA-binding domains of fos and jun - both fos and jun contact DNA directly, Proc. Natl. Acad. Sci. U.S.A., 87, 1032, 1990.
92. Abate, C., Patel, L., Rauscher, F. J., and Curran, T., Redox regulation of fos and jun DNA-binding activity in vitro, Science, 249, 1157, 1990.
93. Kumar, S., Rabson, A. B., and Gelinas, C., The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the V-Rel oncoprotein, Mol. Cell Biol., 12, 3094, 1992.
94. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y. C. E., and Curran, T., Redox activation of fos jun DNA-binding activity is mediated by a DNA-repair enzyme, EMBO J., 11, 3323, 1992.
95. Schreck, R., Rieber, P., and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFκB transcription factor and HIV-1, EMBO J., 10, 2247, 1991.
96. 2 for platelet-derived growth factor signal transduction, Science, 270, 296, 1995.
97. Dröge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H-P., Roth, S., and Gmünder, H., Functions of glutathione and glutathione disulfide in immunology and immunopathology, FASEB J., 8, 1131, 1994.
98. Mihm, S., Galter, D., and Dröge, W., Modulation of transcription factor NFχB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply, FASEB J., 9, 246, 1995.
99. Staal, F. J. T., Ela, S. W., Roederer, M., Anderson, M. T., Herzenberg, L. A., and Herzenberg, L. A., Glutathione deficiency and human immunodeficiency virus infection, Lancet, 339, 909, 1992.
100. Roederer, M., Staal, F. J. T., Anderson, M., Rabin, R., Raju, P. A., Herzenberg, L. A., and Herzenberg, L. A., Disregulation of leukocyte glutathione in AIDS, Ann. N.Y. Acad. Sci., 677, 113, 1993.
101. Aukrust, P., Svardal, A. M., Muller, F., Lunden, B., Berge, R. K., Ueland, P. M., and Froland, S. S., Increased levels of oxidized glutathione in CD4(+) lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type-I infection, Blood, 86, 258, 1995.
102. Goodbourn, S., Transcriptional regulation in activated T cells, Curr. Biol., 4, 930, 1994.
103. Jain, J., Loh, C., and Rao, A., Transcriptional regulation of the IL-2 gene, Curr. Opin. Immunol., 7, 333, 1995.
104. Crabtree, G. R. and Clipstone, N. A., Signal transmission between the plasma membrane and nucleus of T lymphocytes, Annu. Rev. Biochem., 63, 1045, 1994.
105. Kelly, K. and Siebenlist, U., Immediate-early genes induced by antigen receptor stimulation, Curr. Opin. Immunol., 7, 327, 1995.
106. Rao, A., NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes, Immunol. Today, 15, 274, 1994.
107. Shaw, K. T. Y., Ho, A. M., Raghavan, A., Kim, J., Jain, J. N., Park, J. C., Sharma, S., Rao, A., and Hogan, P. G., Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells, Proc. Natl. Acad. Sci. U.S.A., 92, 11205, 1995.
108. Karin, M. and Hunter, T., Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus, Curr. Biol., 5, 747, 1995.
109. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S., Rel/NF-κB family: intimate tales of association and dissociation, Genes Dev., 9, 2723, 1995.
110. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A., and Benneriah, Y., Stimulation-dependent IκB-α phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway, Proc. Natl. Acad. Sci. U.S.A., 92, 10599, 1995.
111. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis, Science, 270, 286, 1995.
112. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S., Jr., Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 1995.
113. Lai, J. -H. and Tan, T. -H., CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin, J. Biol. Chem., 269, 30077, 1994.
114. Taniguchi, T., Cytokine signaling through nonreceptor protein-tyrosine kinases, Science, 268, 251, 1995.
115. Minami, Y. and Taniguchi, T., IL-2 signaling - recruitment and activation of multiple protein-tyrosine kinases by the components of the IL-2 receptor, Curr. Opin. Cell Biol., 7, 156, 1995.
116. Noguchi, M., Yi, H. F., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W., and Leonard, W. J., Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans, Cell, 73, 147, 1993.
117. Ihle, J. N., Cytokine receptor signalling, Nature, 377, 591, 1995.
118. Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J. N., and Taniguchi, T., Critical role of the interleukin-2 (IL-2) receptor γ-chain-associated JAK3 in the IL-2-induced c-fos and c-myc, but not Bcl-2, gene induction, Proc. Natl. Acad. Sci. U.S.A., 92, 8724, 1995.
119. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J., Cloning of p27(KIP1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell, 78, 59, 1994.
120. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M., Interleukin-2-mediated elimination of the p27(KIP1) cyclin-dependent kinase inhibitor prevented by rapamycin, Nature, 372, 570, 1994.
121. Morice, W. G., Wiederrecht, G., Brunn, G. J., Siekierka, J. J., and Abraham, R. T., Rapamycin inhibition of interleukin-2-dependent p33CDK2 and p34CDC2 kinase activation in T-lymphocytes, J. Biol. Chem., 268, 22737, 1993.
122. Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., and Snyder, S. H., RAFT1 - a mammal ian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORS, Cell, 78, 35, 1994.
123. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses, Curr. Opin. Immunol., 1, 382, 1995.
124. Nagata, S. and Golstein, P., The Fas death factor, Science, 267, 1449, 1995.
125. Rathmell, J. C. and Goodnow, C. C., The Fas track, Curr. Biol., 5, 1218, 1995.
126. Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S., and Golstein, P., TCR CD3 coupling to fas-based cytotoxicity, J. Exp. Med., 181, 781, 1995.
127. Anel, A., Buferne, M., Boyer, C., Schmittverhulst, A. M., and Golstein, P., T-cell receptor-induced fas ligand expression in cytotoxic T-lymphocyte clones is blocked by protein-tyrosine kinase inhibitors and cyclosporine-A, Eur. J. Immunol., 24, 2469, 1994.
128. Reed, J. C., Bcl-2 and the regulation of programmed cell death, J. Cell Biol., 124, 1, 1994.
129. Boise, L. H., Noel, P. J., and Thompson, C. B., CD28 and apoptosis, Curr. Opin. Immunol., 7, 620, 1995.
130. Zheng, L. X., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor, Nature, 377, 348, 1995.
131. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature, 373, 438, 1995.
132. Brunner, T., Mogil, R. J., Laface, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R., Cell-autonomous Fas (CD95) Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature, 373, 441, 1995.
133. Ju, S. T., Panka, D. J., Cui, H. L., Ettinger, R., Elkhatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A., Fas (CD95) FasL interactions required for programmed cell-death after T-cell activation, Nature, 373, 444, 1995.
134. Los, M., Van De Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K., Requirement of an ICE/CED-3 protease for Fas/ APO-1-mediated apoptosis, Nature, 375, 81, 1995.
135. Enari, M., Hug, H., and Nagata, S., Involvement of an ICE-like protease in Fas-mediated apoptosis, Nature, 375, 78, 1995.
136. Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier, H., and Fotedar, A., Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B, Mol. Cell. Biol., 15, 932, 1995.
137. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., and Spiegel, S., Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate, Nature, 381, 800, 1996.
138. Zhang, J. D., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A., BCL-2 interrupts the ceramide-mediated pathway of cell-death, Proc. Natl. Acad. Sci. U.S.A., 93, 5325, 1996.
139. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D., Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway, Immunity, 2, 341, 1995.
140. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., and de Villartay, J. P., Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science, 268, 1347, 1995.
141. Pleiman, C. M., D'Ambrosio, D., and Cambier, J. C., The B-cell antigen receptor complex: structure and signal transduction, Immunol. Today, 15, 393, 1994.
142. Law, C. L., Sidorenko, S. P., and Clark, E. A., Regulation of lymphocyte-activation by the cell-surface molecule CD22, Immunol. Today, 15, 442, 1994.
143. Doody, G. M., Justement, L. B., DeLebrias, C. C., Matthews, R. J., Lin, J. J., Thomas, M. L., and Fearon, D. T., A role in B-cell activation for CD22 and the protein-tyrosine-phosphatase SHP, Science, 269, 242, 1995.
144. D'Ambrosio, D., Hippen, K. L., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A., and Cambier, J. C., Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FCγRIIB1, Science, 268, 293, 1995.
145. Choquet, D., Partiseti, M., Amigorena, S., Bonnerot, C., Fridman, W. H., and Korn, H., Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes, J. Cell Biol. 121, 355, 1993.
146. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., and Ravetch, J. V., A 13-amino-acid motif in the cytoplasmic domain of FCγRIIB modulates B-cell receptor signaling, Nature, 368, 70, 1994.
147. Nowak, M. A., May, R. M., Phillips, R. E., Rowland Jones, S., Lalloo, D. G., McAdam, S., Klenerman, P., Koppe, B., Sigmund, K., Bangham, C. R. M., and McMichael, A. J., Antigenic oscillations and shifting immunodominance in HIV-1 infections, Nature, 375, 606, 1995.
148. Klenerman, P., Rowland Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Koppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E., and McMichael, A. J., Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 GAG variants, Nature, 369, 403, 1994.
149. Sharma, V. K., Li, B., Khanna, A., Sehajpal, P. K., and Suthanthiran, M., Which way for drug-mediated immunosuppression?, Curr. Opin. Immunol., 6, 784, 1994.
150. Waldmann, H. and Cobbold, D., The use of monoclonal antibodies to achieve immunological tolerance, Immunol. Today, 14, 247, 1993.
151. Fairchild, P. J., Thorpe, C. J., Travers, P. J., and Wraith, D. C., Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease, Immunology, 81, 487, 1994.
152. Fairchild, P. J., Wildgoose, R., Atherton, E., Webb, S., and Wraith, D. C., An autoantigenic T-cell epitope forms unstable complexes with class-II MHC - a novel route for escape from tolerance induction, Int. Immunity, 5, 1151, 1993.
153. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D., and Wraith, D., Low avidity recognition of self-antigen by T cells permits escape from central tolerance, Immunity, 3, 407, 1995.
154. Liu, G. Y. and Wraith, D. C., Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice - implications for autoimmunity, Int. Immunol., 7, 1255, 1995.
155. Weiss, A., T-cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases, Cell, 73, 209, 1993.